Ionis Pharmaceuticals, Inc. (IONS)
USD 25.98
(-4.1%)
USD 25.98
(-4.1%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -366.28 Million USD | -35.66% |
| 2022 | -270 Million USD | -831.03% |
| 2021 | -29 Million USD | 94.05% |
| 2020 | -487 Million USD | -265.65% |
| 2019 | 294 Million USD | 7.4% |
| 2018 | 273.74 Million USD | 4685.28% |
| 2017 | -5.97 Million USD | 93.1% |
| 2016 | -86.55 Million USD | 1.95% |
| 2015 | -88.27 Million USD | -126.45% |
| 2014 | -38.98 Million USD | 35.72% |
| 2013 | -60.64 Million USD | 7.38% |
| 2012 | -65.47 Million USD | 22.79% |
| 2011 | -84.8 Million USD | -38.45% |
| 2010 | -61.25 Million USD | -139.5% |
| 2009 | 155.06 Million USD | 1396.21% |
| 2008 | -11.96 Million USD | -8.81% |
| 2007 | -10.99 Million USD | 76.05% |
| 2006 | -45.9 Million USD | 36.6% |
| 2005 | -72.4 Million USD | 49.19% |
| 2004 | -142.5 Million USD | -50.01% |
| 2003 | -94.99 Million USD | -31.5% |
| 2002 | -72.24 Million USD | 2.15% |
| 2001 | -73.83 Million USD | -38.04% |
| 2000 | -53.48 Million USD | 9.65% |
| 1999 | -59.2 Million USD | -37.67% |
| 1998 | -43 Million USD | -38.26% |
| 1997 | -31.1 Million USD | -17.36% |
| 1996 | -26.5 Million USD | -11.81% |
| 1995 | -23.7 Million USD | -30.22% |
| 1994 | -18.2 Million USD | 4.71% |
| 1993 | -19.1 Million USD | 2.05% |
| 1992 | -19.5 Million USD | -124.14% |
| 1991 | -8.7 Million USD | -93.33% |
| 1990 | -4.5 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -66.26 Million USD | 53.6% |
| 2024 Q1 | -142.8 Million USD | -1441.65% |
| 2023 Q2 | -85 Million USD | 31.45% |
| 2023 Q4 | -9.26 Million USD | 93.7% |
| 2023 Q3 | -147 Million USD | -72.94% |
| 2023 Q1 | -124 Million USD | -138.46% |
| 2023 FY | -366.28 Million USD | -35.66% |
| 2022 Q4 | -52 Million USD | -10.66% |
| 2022 Q3 | -46.99 Million USD | 55.3% |
| 2022 Q1 | -65.16 Million USD | -128.96% |
| 2022 Q2 | -105.13 Million USD | -61.34% |
| 2022 FY | -270 Million USD | -831.03% |
| 2021 Q3 | -82.46 Million USD | -1.97% |
| 2021 Q4 | 225 Million USD | 372.84% |
| 2021 Q1 | -89.86 Million USD | 73.57% |
| 2021 Q2 | -80.87 Million USD | 10.01% |
| 2021 FY | -29 Million USD | 94.05% |
| 2020 Q1 | -48.22 Million USD | -126.21% |
| 2020 Q2 | -31.84 Million USD | 33.97% |
| 2020 Q3 | -30.94 Million USD | 2.83% |
| 2020 FY | -487 Million USD | -265.65% |
| 2020 Q4 | -340 Million USD | -998.76% |
| 2019 Q3 | 26.16 Million USD | 2716.3% |
| 2019 Q4 | 184 Million USD | 603.28% |
| 2019 Q1 | 84.44 Million USD | -73.62% |
| 2019 FY | 294 Million USD | 7.4% |
| 2019 Q2 | -1 Million USD | -101.18% |
| 2018 Q1 | -1.42 Million USD | -151.75% |
| 2018 Q3 | -4.55 Million USD | 88.7% |
| 2018 Q4 | 320.07 Million USD | 7120.79% |
| 2018 Q2 | -40.35 Million USD | -2742.11% |
| 2018 FY | 273.74 Million USD | 4685.28% |
| 2017 Q4 | 2.74 Million USD | 381.15% |
| 2017 Q2 | -11.2 Million USD | -423.13% |
| 2017 Q1 | 3.46 Million USD | -86.59% |
| 2017 FY | -5.97 Million USD | 93.1% |
| 2017 Q3 | -976 Thousand USD | 91.29% |
| 2016 Q3 | 7.35 Million USD | 112.93% |
| 2016 Q4 | 25.86 Million USD | 251.86% |
| 2016 FY | -86.55 Million USD | 1.95% |
| 2016 Q1 | -62.91 Million USD | 11.92% |
| 2016 Q2 | -56.85 Million USD | 9.63% |
| 2015 Q3 | -35.77 Million USD | -200.36% |
| 2015 FY | -88.27 Million USD | -126.45% |
| 2015 Q1 | -16.71 Million USD | -153.83% |
| 2015 Q4 | -71.43 Million USD | -99.67% |
| 2015 Q2 | 35.64 Million USD | 313.24% |
| 2014 FY | -38.98 Million USD | 35.72% |
| 2014 Q3 | -26.67 Million USD | -120.81% |
| 2014 Q4 | 31.05 Million USD | 216.41% |
| 2014 Q2 | -12.08 Million USD | 61.38% |
| 2014 Q1 | -31.28 Million USD | -28.85% |
| 2013 Q2 | -10.12 Million USD | -505.62% |
| 2013 Q1 | -1.67 Million USD | 36.59% |
| 2013 FY | -60.64 Million USD | 7.38% |
| 2013 Q4 | -24.27 Million USD | 1.2% |
| 2013 Q3 | -24.57 Million USD | -142.64% |
| 2012 Q2 | -1.2 Million USD | 94.97% |
| 2012 Q1 | -23.99 Million USD | -19.76% |
| 2012 Q3 | -37.63 Million USD | -3018.39% |
| 2012 Q4 | -2.63 Million USD | 92.99% |
| 2012 FY | -65.47 Million USD | 22.79% |
| 2011 Q2 | -17.88 Million USD | 10.53% |
| 2011 Q3 | -26.88 Million USD | -50.27% |
| 2011 FY | -84.8 Million USD | -38.45% |
| 2011 Q4 | -20.03 Million USD | 25.47% |
| 2011 Q1 | -19.99 Million USD | -42.96% |
| 2010 Q1 | -9.65 Million USD | -38.8% |
| 2010 FY | -61.25 Million USD | -139.5% |
| 2010 Q2 | -25.15 Million USD | -160.45% |
| 2010 Q3 | -12.45 Million USD | 50.49% |
| 2010 Q4 | -13.98 Million USD | -12.3% |
| 2009 Q3 | -6.92 Million USD | -139.09% |
| 2009 FY | 155.06 Million USD | 1396.21% |
| 2009 Q4 | -6.95 Million USD | -0.49% |
| 2009 Q2 | -2.89 Million USD | -101.69% |
| 2009 Q1 | 171.84 Million USD | 2084.79% |
| 2008 Q2 | -2.2 Million USD | 48.47% |
| 2008 Q1 | -4.28 Million USD | 38.41% |
| 2008 FY | -11.96 Million USD | -8.81% |
| 2008 Q3 | 3.18 Million USD | 244.38% |
| 2008 Q4 | -8.65 Million USD | -371.58% |
| 2007 Q2 | -11.02 Million USD | 15.33% |
| 2007 Q4 | -6.95 Million USD | -134.77% |
| 2007 Q3 | 20 Million USD | 281.49% |
| 2007 Q1 | -13.02 Million USD | 7.96% |
| 2007 FY | -10.99 Million USD | 76.05% |
| 2006 FY | -45.9 Million USD | 36.6% |
| 2006 Q4 | -14.14 Million USD | -16.86% |
| 2006 Q3 | -12.1 Million USD | -457.32% |
| 2006 Q2 | -2.17 Million USD | 87.57% |
| 2006 Q1 | -17.48 Million USD | -120.9% |
| 2005 Q1 | -29.65 Million USD | 48.46% |
| 2005 Q3 | -15.17 Million USD | 22.82% |
| 2005 Q2 | -19.65 Million USD | 33.71% |
| 2005 FY | -72.4 Million USD | 49.19% |
| 2005 Q4 | -7.91 Million USD | 47.84% |
| 2004 Q3 | -32.7 Million USD | -26.05% |
| 2004 Q1 | -26.3 Million USD | -3.67% |
| 2004 FY | -142.5 Million USD | -50.01% |
| 2004 Q2 | -25.94 Million USD | 1.36% |
| 2004 Q4 | -57.54 Million USD | -75.92% |
| 2003 Q3 | -22.2 Million USD | 3.87% |
| 2003 Q4 | -25.37 Million USD | -14.29% |
| 2003 Q2 | -23.09 Million USD | 5.03% |
| 2003 Q1 | -24.32 Million USD | -53.65% |
| 2003 FY | -94.99 Million USD | -31.5% |
| 2002 FY | -72.24 Million USD | 2.15% |
| 2002 Q1 | -17.97 Million USD | -15.02% |
| 2002 Q3 | -17.57 Million USD | 15.76% |
| 2002 Q4 | -15.82 Million USD | 9.94% |
| 2002 Q2 | -20.86 Million USD | -16.1% |
| 2001 Q3 | -12.31 Million USD | 46.55% |
| 2001 FY | -73.83 Million USD | -38.04% |
| 2001 Q4 | -15.62 Million USD | -26.86% |
| 2001 Q2 | -23.04 Million USD | -0.86% |
| 2001 Q1 | -22.84 Million USD | -47.91% |
| 2000 Q3 | -5.4 Million USD | 62.18% |
| 2000 Q1 | -18.32 Million USD | -4.13% |
| 2000 Q2 | -14.3 Million USD | 21.96% |
| 2000 FY | -53.48 Million USD | 9.65% |
| 2000 Q4 | -15.44 Million USD | -185.58% |
| 1999 Q4 | -17.6 Million USD | -41.94% |
| 1999 Q3 | -12.4 Million USD | 24.85% |
| 1999 Q2 | -16.5 Million USD | -30.95% |
| 1999 FY | -59.2 Million USD | -37.67% |
| 1999 Q1 | -12.6 Million USD | 24.55% |
| 1998 Q2 | -13.8 Million USD | -20.0% |
| 1998 FY | -43 Million USD | -38.26% |
| 1998 Q4 | -16.7 Million USD | -1570.0% |
| 1998 Q3 | -1 Million USD | 92.75% |
| 1998 Q1 | -11.5 Million USD | -5.5% |
| 1997 Q3 | -2.2 Million USD | 76.6% |
| 1997 FY | -31.1 Million USD | -17.36% |
| 1997 Q1 | -8.6 Million USD | -6.17% |
| 1997 Q2 | -9.4 Million USD | -9.3% |
| 1997 Q4 | -10.9 Million USD | -395.45% |
| 1996 FY | -26.5 Million USD | -11.81% |
| 1996 Q4 | -8.1 Million USD | -35.0% |
| 1996 Q3 | -6 Million USD | 17.81% |
| 1996 Q2 | -7.3 Million USD | -43.14% |
| 1996 Q1 | -5.1 Million USD | 0.0% |
| 1995 Q1 | -5.9 Million USD | 1.67% |
| 1995 Q4 | -5.1 Million USD | 26.09% |
| 1995 Q2 | -5.9 Million USD | 0.0% |
| 1995 Q3 | -6.9 Million USD | -16.95% |
| 1995 FY | -23.7 Million USD | -30.22% |
| 1994 FY | -18.2 Million USD | 4.71% |
| 1994 Q4 | -6 Million USD | -11.11% |
| 1994 Q2 | -5.1 Million USD | -200.0% |
| 1994 Q1 | -1.7 Million USD | 63.04% |
| 1994 Q3 | -5.4 Million USD | -5.88% |
| 1993 Q4 | -4.6 Million USD | 0.0% |
| 1993 FY | -19.1 Million USD | 2.05% |
| 1993 Q1 | -5.1 Million USD | 3.77% |
| 1993 Q2 | -4.8 Million USD | 5.88% |
| 1993 Q3 | -4.6 Million USD | 4.17% |
| 1992 Q4 | -5.3 Million USD | -8.16% |
| 1992 FY | -19.5 Million USD | -124.14% |
| 1992 Q2 | -4.3 Million USD | 14.0% |
| 1992 Q1 | -5 Million USD | -56.25% |
| 1992 Q3 | -4.9 Million USD | -13.95% |
| 1991 FY | -8.7 Million USD | -93.33% |
| 1991 Q3 | -2.4 Million USD | -20.0% |
| 1991 Q1 | -1.1 Million USD | 0.0% |
| 1991 Q2 | -2 Million USD | -81.82% |
| 1991 Q4 | -3.2 Million USD | -33.33% |
| 1990 Q2 | - USD | 0.0% |
| 1990 FY | -4.5 Million USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -150.199% |
| Alkermes plc | 355.75 Million USD | 202.96% |
| Agenus Inc. | -245.76 Million USD | -49.042% |
| Aptorum Group Limited | -2.82 Million USD | -12867.496% |
| Ardelyx, Inc. | -66.06 Million USD | -454.416% |
| Dyadic International, Inc. | -6.79 Million USD | -5290.157% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -39033.12% |
| Lantern Pharma Inc. | -15.96 Million USD | -2194.804% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -1824.895% |
| Novavax, Inc. | -545.06 Million USD | 32.799% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -528.353% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -396.39% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1875.003% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -3567.995% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -521.006% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 1.966% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1404.916% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -880.948% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -122.566% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -399.388% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1705.165% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -488.364% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1027.554% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -176.457% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 16.799% |
| AlloVir, Inc. | -190.41 Million USD | -92.359% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -78.437% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1187.382% |
| Bicycle Therapeutics plc | -180.66 Million USD | -102.744% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -104.568% |
| ChromaDex Corporation | -4.93 Million USD | -7317.699% |
| Chimerix, Inc. | -82.09 Million USD | -346.173% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -721.208% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -258.858% |
| CRISPR Therapeutics AG | -153.61 Million USD | -138.452% |
| Precision BioSciences, Inc. | -61.31 Million USD | -497.345% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -127.609% |
| Fortress Biotech, Inc. | -60.63 Million USD | -504.064% |
| Fortress Biotech, Inc. | -60.63 Million USD | -504.064% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -348.99% |
| ImmuCell Corporation | -5.77 Million USD | -6243.056% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -224.259% |
| Immix Biopharma, Inc. | -15.42 Million USD | -2274.464% |
| Incyte Corporation | 597.59 Million USD | 161.293% |
| Innoviva, Inc. | 179.72 Million USD | 303.807% |
| IO Biotech, Inc. | -86.08 Million USD | -325.503% |
| Jaguar Health, Inc. | -41.3 Million USD | -786.891% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -139.415% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 802.316% |
| ContextLogic Inc. | -317 Million USD | -15.548% |
| MiMedx Group, Inc. | 67.43 Million USD | 643.137% |
| MEI Pharma, Inc. | 17.77 Million USD | 2160.333% |
| NextCure, Inc. | -62.72 Million USD | -483.974% |
| Onconetix, Inc. | -37.4 Million USD | -879.121% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -827.8% |
| Opthea Limited | -220.24 Million USD | -66.311% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -615.975% |
| Vaxcyte, Inc. | -402.26 Million USD | 8.944% |
| PDS Biotechnology Corporation | -42.94 Million USD | -752.975% |
| Precigen, Inc. | -95.9 Million USD | -281.93% |
| Pharming Group N.V. | -10.54 Million USD | -3372.564% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -81.697% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -1392.426% |
| PureTech Health plc | -65.69 Million USD | -457.538% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1359.83% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -72.597% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1404.916% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -42.064% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1244.761% |
| Acelyrin, Inc. | -381.64 Million USD | 4.023% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -2920214.542% |
| Summit Therapeutics Inc. | -614.92 Million USD | 40.434% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -974.121% |
| Senti Biosciences, Inc. | -92.91 Million USD | -294.199% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -249.847% |
| Elevation Oncology, Inc. | -45.7 Million USD | -701.431% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -942.362% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -2702.095% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -5379.222% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1147.483% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -4208.74% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -536.875% |
| Seer, Inc. | -86.27 Million USD | -324.547% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -446.736% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -456.962% |
| ESSA Pharma Inc. | -26.58 Million USD | -1277.93% |
| GlycoMimetics, Inc. | -36.89 Million USD | -892.661% |
| GT Biopharma, Inc. | -7.59 Million USD | -4721.456% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -51.759% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -605.414% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 612.934% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -573.048% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -645.696% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -3582.1% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 36.058% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -10108.64% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -617.392% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -49.142% |
| Aptose Biosciences Inc. | -51.2 Million USD | -615.305% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -272.628% |
| Soligenix, Inc. | -6.14 Million USD | -5864.861% |
| Century Therapeutics, Inc. | -136.67 Million USD | -168.002% |
| Kura Oncology, Inc. | -152.63 Million USD | -139.981% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -310.552% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -3375.859% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 64875.496% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -64273.638% |
| Autolus Therapeutics plc | -208.38 Million USD | -75.775% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -409.452% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -417.39% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -1590.447% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -62.613% |
| GRI Bio, Inc. | -13.03 Million USD | -2709.588% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -8759.09% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -195.192% |
| IGM Biosciences, Inc. | -246.41 Million USD | -48.645% |
| INmune Bio, Inc. | -30 Million USD | -1120.628% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -231.304% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -768.104% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2194.787% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -2219.002% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -513.699% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -262.061% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -32.652% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -53.972% |
| Verastem, Inc. | -87.36 Million USD | -319.25% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -575.954% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -127.033% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -213.983% |
| Histogen Inc. | -10.62 Million USD | -3348.696% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -2463.815% |
| Surrozen, Inc. | -43.04 Million USD | -750.997% |
| Organovo Holdings, Inc. | -14.67 Million USD | -2396.667% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -7100.391% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -599.834% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -1349.891% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1259.737% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -4282.939% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -142.437% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -648.652% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1132.249% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -3415.995% |
| Apollomics, Inc. | -172.6 Million USD | -112.215% |
| Amarin Corporation plc | -59.11 Million USD | -519.647% |
| Mesoblast Limited | -87.95 Million USD | -316.442% |
| Turnstone Biologics Corp. | -55.2 Million USD | -563.562% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -149.239% |
| Synaptogenix, Inc. | -6.03 Million USD | -5965.84% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -2159.909% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -369.477% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -7544.55% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -4259.408% |
| Exelixis, Inc. | 207.76 Million USD | 276.298% |
| Better Therapeutics, Inc. | -39.76 Million USD | -821.242% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -154.457% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 30.71% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2909.244% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -4599.173% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1091.213% |
| Gritstone bio, Inc. | -138.49 Million USD | -164.486% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -468.194% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -9057.264% |
| Avid Bioservices, Inc. | -140.75 Million USD | -160.233% |
| Insmed Incorporated | -749.56 Million USD | 51.134% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -2311.441% |
| MediWound Ltd. | -6.71 Million USD | -5353.931% |
| OmniAb, Inc. | -50.61 Million USD | -623.614% |
| Alector, Inc. | -130.39 Million USD | -180.914% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -222.083% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -606.475% |
| Zai Lab Limited | -334.62 Million USD | -9.463% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -13.056% |
| Aura Biosciences, Inc. | -76.4 Million USD | -379.382% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -56.111% |
| Immunic, Inc. | -93.61 Million USD | -291.281% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -169.54% |
| Veracyte, Inc. | -74.4 Million USD | -392.293% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -4672.114% |
| FibroGen, Inc. | -284.23 Million USD | -28.869% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1296.333% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -5131.245% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -1844.947% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 188.297% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -1523.968% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 843.411% |
| TG Therapeutics, Inc. | 12.67 Million USD | 2990.515% |
| Galecto, Inc. | -38.34 Million USD | -855.138% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -1841.514% |
| Fortrea Holdings Inc. | -3.4 Million USD | -10673.118% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -189.225% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -2003.762% |
| XBiotech Inc. | -24.55 Million USD | -1391.575% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -468.194% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -484.375% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -272.144% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1609.46% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -563.646% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 39.62% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -436.643% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -643251.951% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -61.688% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -1544.934% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -66.713% |
| NexImmune, Inc. | -32.34 Million USD | -1032.456% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -6828.608% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -2507.78% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 109.265% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -1412.266% |
| Scopus BioPharma Inc. | -11.6 Million USD | -3054.965% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -213.606% |
| Ainos, Inc. | -13.77 Million USD | -2559.923% |
| Pluri Inc. | -20.88 Million USD | -1653.571% |
| Prothena Corporation plc | -147.02 Million USD | -149.127% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -221.668% |
| Celularity Inc. | -196.29 Million USD | -86.6% |
| Rallybio Corporation | -74.56 Million USD | -391.237% |
| Cue Biopharma, Inc. | -50.73 Million USD | -621.988% |
| MeiraGTx Holdings plc | -84.02 Million USD | -335.915% |
| Omeros Corporation | -117.81 Million USD | -210.905% |
| Humacyte, Inc. | -110.77 Million USD | -230.655% |
| Immunocore Holdings plc | -55.28 Million USD | -562.517% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1936.733% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -1497.34% |
| Blueprint Medicines Corporation | -506.98 Million USD | 27.752% |
| CalciMedica, Inc. | -34.35 Million USD | -966.118% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -441.243% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -159.033% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -120.935% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -29.313% |
| Pulmatrix, Inc. | -14.12 Million USD | -2493.91% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -940.733% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -343.242% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 23.879% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -249.273% |
| Cytokinetics, Incorporated | -526.24 Million USD | 30.396% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -915.627% |
| Nutriband Inc. | -5.48 Million USD | -6577.576% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -806.2% |
| Vor Biopharma Inc. | -117.86 Million USD | -210.773% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 108.422% |
| Evogene Ltd. | -23.87 Million USD | -1433.925% |
| ProKidney Corp. | -35.46 Million USD | -932.722% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -205.842% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -4568.806% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 43.053% |
| CorMedix Inc. | -46.33 Million USD | -690.445% |
| BioLineRx Ltd. | -60.61 Million USD | -504.293% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -260.007% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -791.945% |
| Atai Life Sciences N.V. | -40.22 Million USD | -810.616% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -354.166% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -385.012% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -25.358% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1213.983% |
| MediciNova, Inc. | -8.57 Million USD | -4173.293% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -197.124% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -4272.607% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1310.596% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -53.105% |
| Biomea Fusion, Inc. | -117.25 Million USD | -212.384% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 41.544% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1143.08% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -139.149% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -74.955% |
| Absci Corporation | -110.56 Million USD | -231.283% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1114.879% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -263.246% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -55.247% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 2700.724% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -89.823% |
| Allakos Inc. | -185.7 Million USD | -97.245% |
| Imunon, Inc. | -19.51 Million USD | -1776.948% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -276.315% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 445.097% |
| BioAtla, Inc. | -123.46 Million USD | -196.679% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2909.244% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -2178.181% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -11.923% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -891.329% |
| XOMA Corporation | -40.83 Million USD | -797.078% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -259.562% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -209.068% |
| aTyr Pharma, Inc. | -50.38 Million USD | -626.917% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -317.758% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -141.36% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -54.074% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -942.985% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -4426.554% |
| Akari Therapeutics, Plc | -10 Million USD | -3559.932% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -543956.443% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 230.076% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -5395.747% |
| UroGen Pharma Ltd. | -102.24 Million USD | -258.247% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -242.987% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -4609.751% |
| Orgenesis Inc. | -55.36 Million USD | -561.632% |
| Entera Bio Ltd. | -8.88 Million USD | -4020.666% |
| GH Research PLC | -35.58 Million USD | -929.269% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -1657.61% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -373.311% |
| Xencor, Inc. | -126.08 Million USD | -190.503% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -9626.898% |
| Replimune Group, Inc. | -215.79 Million USD | -69.739% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1622.358% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 14698.884% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -5395.747% |
| Portage Biotech Inc. | -75.33 Million USD | -386.184% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -4272.607% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -278.962% |
| OncoCyte Corporation | -27.78 Million USD | -1218.477% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -2629.971% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -3193.489% |
| Purple Biotech Ltd. | -19.88 Million USD | -1742.485% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -5118.493% |
| scPharmaceuticals Inc. | -54.81 Million USD | -568.283% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1992.329% |
| HilleVax, Inc. | -123.56 Million USD | -196.429% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -3524.082% |
| Tharimmune, Inc. | -9.31 Million USD | -3830.489% |
| Genprex, Inc. | -30.86 Million USD | -1086.91% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -55.255% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1117.14% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -20454.77% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -6816.257% |
| OKYO Pharma Limited | -16.82 Thousand USD | -2176874.656% |
| Savara Inc. | -54.69 Million USD | -569.652% |
| Curis, Inc. | -47.41 Million USD | -672.543% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1114.42% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -2271.537% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -6477.231% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1128.529% |
| BeiGene, Ltd. | -881.7 Million USD | 58.457% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -1620.137% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 16.06% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -363.917% |
| Erasca, Inc. | -125.04 Million USD | -192.93% |
| bluebird bio, Inc. | -211.91 Million USD | -72.847% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -7224.992% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 318.489% |
| DBV Technologies S.A. | -72.72 Million USD | -403.652% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -7224.992% |
| Moderna, Inc. | -4.71 Billion USD | 92.23% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -812.135% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -6332.842% |
| Molecular Templates, Inc. | -8.12 Million USD | -4408.69% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -506.554% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -228.805% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -170.617% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -664.386% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -158.989% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -90.367% |
| MacroGenics, Inc. | -9.05 Million USD | -3943.784% |
| RenovoRx, Inc. | -10.23 Million USD | -3479.808% |
| Adicet Bio, Inc. | -142.65 Million USD | -156.758% |
| Prime Medicine, Inc. | -198.13 Million USD | -84.869% |
| Aditxt, Inc. | -32.38 Million USD | -1031.181% |
| Adagene Inc. | -18.94 Million USD | -1833.278% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4909.572% |
| Quantum-Si incorporated | -95.96 Million USD | -281.707% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -207.728% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -2412.634% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 376.797% |
| SciSparc Ltd. | -5.12 Million USD | -7051.23% |
| Vericel Corporation | -3.18 Million USD | -11411.188% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -304493.61% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1120.736% |
| Generation Bio Co. | -126.61 Million USD | -189.298% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -402.512% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -344.295% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -39.729% |
| Invivyd, Inc. | -198.64 Million USD | -84.394% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -7.11% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -4116.692% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1706.095% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -3609.601% |
| 2seventy bio, Inc. | -217.57 Million USD | -68.353% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1197.093% |
| Clene Inc. | -49.5 Million USD | -639.912% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -1543.456% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -640.96% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1310.596% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -11.65% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1025.548% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1712.174% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -270.766% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -389.988% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -127.783% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 40.447% |
| Evaxion Biotech A/S | -22.12 Million USD | -1555.53% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -353.684% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -83.081% |
| Trevena, Inc. | -40.28 Million USD | -809.146% |
| Surrozen, Inc. | -43.04 Million USD | -750.997% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -429.82% |
| Cingulate Inc. | -23.53 Million USD | -1456.349% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -5199.277% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -818.931% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -4650.377% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -306.037% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -497.667% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -515.576% |
| Clearmind Medicine Inc. | -11.95 Million USD | -2963.865% |
| Kronos Bio, Inc. | -112.67 Million USD | -225.088% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -429.338% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -14442044.443% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -326.435% |
| Statera Biopharma, Inc. | -174.4 Million USD | -110.017% |
| ImmunityBio, Inc. | -583.19 Million USD | 37.193% |
| Korro Bio, Inc. | -81.17 Million USD | -351.247% |
| Kineta, Inc. | -14.09 Million USD | -2497.957% |
| BioVie Inc. | -32.12 Million USD | -1040.348% |
| Codexis, Inc. | -76.24 Million USD | -380.438% |
| Celularity Inc. | -196.29 Million USD | -86.6% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -70.74% |
| Celcuity Inc. | -63.77 Million USD | -474.304% |
| Virax Biolabs Group Limited | -6.73 Million USD | -5339.727% |
| Cibus, Inc. | -267.62 Million USD | -36.864% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -808.312% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -922.831% |
| IN8bio, Inc. | -30 Million USD | -1120.669% |
| Kodiak Sciences Inc. | -260.49 Million USD | -40.614% |
| Annexon, Inc. | -134.23 Million USD | -172.865% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -212.624% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -498.233% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1061.191% |
| Eyenovia, Inc. | -27.26 Million USD | -1243.622% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1796.475% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -68364.673% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -379.407% |
| Arcellx, Inc. | -70.69 Million USD | -418.158% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -783.873% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -173.724% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1119.449% |
| Moolec Science SA | -51.78 Million USD | -607.268% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -599.406% |
| Geron Corporation | -184.12 Million USD | -98.931% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -772.65% |
| Royalty Pharma plc | 1.13 Billion USD | 132.277% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -169.415% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -4019.367% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1624.248% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -113.366% |
| Humacyte, Inc. | -110.77 Million USD | -230.655% |
| Structure Therapeutics Inc. | -89.62 Million USD | -308.71% |
| 89bio, Inc. | -142.18 Million USD | -157.605% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -431.157% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -3429.787% |
| Genelux Corporation | -28.29 Million USD | -1194.434% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1160.231% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -106.802% |
| Notable Labs, Ltd. | -11.26 Million USD | -3151.829% |
| Liquidia Corporation | -78.5 Million USD | -366.594% |
| Mustang Bio, Inc. | -51.6 Million USD | -609.829% |
| Immunovant, Inc. | -259.33 Million USD | -41.24% |
| Quantum-Si incorporated | -95.96 Million USD | -281.707% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -402.802% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1789.923% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -281.588% |
| Acasti Pharma Inc. | -12.85 Million USD | -2749.809% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -1530.993% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2194.787% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -100.822% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -8415.275% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -2837.338% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1142.026% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -839.484% |
| PepGen Inc. | -78.62 Million USD | -365.859% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1130.428% |
| United Therapeutics Corporation | 984.8 Million USD | 137.194% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -1545.49% |
| Solid Biosciences Inc. | -96.01 Million USD | -281.488% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -7544.55% |
| Immuneering Corporation | -53.47 Million USD | -585.01% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -7100.391% |
| Silo Pharma, Inc. | -3.7 Million USD | -9797.795% |
| Belite Bio, Inc | -31.63 Million USD | -1057.96% |
| XOMA Corporation | -40.83 Million USD | -797.078% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -573.753% |
| Bionomics Limited | -15.49 Billion USD | 97.636% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -336.133% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1156.254% |
| uniQure N.V. | -308.47 Million USD | -18.74% |
| Cassava Sciences, Inc. | -97.21 Million USD | -276.772% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4909.572% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -196.756% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1063.699% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -4365.975% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1160.1% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -68364.673% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1296.333% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -2121.935% |
| Altimmune, Inc. | -88.44 Million USD | -314.13% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -141.639% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1156.254% |
| Compugen Ltd. | -18.75 Million USD | -1853.109% |
| Peak Bio, Inc. | -1259.26 USD | -29087300.537% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -695.427% |
| Benitec Biopharma Inc. | -21.75 Million USD | -1583.996% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -8.116% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -341.553% |
| Zura Bio Limited | -60.36 Million USD | -506.836% |
| PolyPid Ltd. | -23.86 Million USD | -1434.825% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -2228.286% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -341.553% |
| Instil Bio, Inc. | -156.08 Million USD | -134.668% |
| argenx SE | -295.05 Million USD | -24.142% |
| Immunome, Inc. | -106.8 Million USD | -242.945% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -761.971% |
| Verona Pharma plc | -54.36 Million USD | -573.704% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -266.59% |
| Shattuck Labs, Inc. | -87.29 Million USD | -319.581% |
| CervoMed Inc. | -2.17 Million USD | -16764.982% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -193.849% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -2650.721% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -740.973% |
| Moolec Science SA | -51.78 Million USD | -607.268% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -2118172.723% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -171.087% |
| AnaptysBio, Inc. | -163.61 Million USD | -123.865% |
| Design Therapeutics, Inc. | -66.86 Million USD | -447.824% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -349.905% |
| NeurAxis, Inc. | -14.62 Million USD | -2404.231% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -866.913% |
| Lumos Pharma, Inc. | -34.03 Million USD | -976.236% |
| Achilles Therapeutics plc | -69.66 Million USD | -425.782% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -266.59% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1737.391% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 12273.864% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -14442044.443% |
| Nutriband Inc. | -5.48 Million USD | -6577.576% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -263.751% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -653.566% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -375.135% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -978.263% |
| MoonLake Immunotherapeutics | -36 Million USD | -917.256% |
| Palisade Bio, Inc. | -12.3 Million USD | -2877.935% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -769.542% |
| Beam Therapeutics Inc. | -132.52 Million USD | -176.386% |
| Neurogene Inc. | -36.31 Million USD | -908.58% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -124.145% |
| AEON Biopharma, Inc. | -52.55 Million USD | -596.944% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -273.201% |
| Sesen Bio, Inc. | -19.88 Million USD | -1742.114% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -411.687% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -2827.034% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 17.51% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -228.313% |
| Athira Pharma, Inc. | -117.67 Million USD | -211.277% |
| Vaccinex, Inc. | -20.25 Million USD | -1708.73% |
| HCW Biologics Inc. | -24.99 Million USD | -1365.479% |
| XOMA Corporation | -40.83 Million USD | -797.078% |
| Nektar Therapeutics | -276.05 Million USD | -32.685% |
| Arvinas, Inc. | -367.3 Million USD | 0.276% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -543956.443% |
| Merus N.V. | -154.93 Million USD | -136.407% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -275.956% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1067.073% |
| Rezolute, Inc. | -68.45 Million USD | -435.044% |
| Clene Inc. | -49.5 Million USD | -639.912% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2274.861% |
| BeyondSpring Inc. | -21.02 Million USD | -1642.062% |
| Synlogic, Inc. | -57.28 Million USD | -539.443% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -2977.775% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -3283.392% |
| Peak Bio, Inc. | -1259.26 USD | -29087300.537% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -880.213% |
| Krystal Biotech, Inc. | 10.93 Million USD | 3450.585% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -155.967% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -12.667% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -7830.045% |
| MannKind Corporation | -11.93 Million USD | -2968.236% |
| Ikena Oncology, Inc. | -68.16 Million USD | -437.344% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1642.974% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -294.14% |
| Gossamer Bio, Inc. | -179.81 Million USD | -103.699% |
| CohBar, Inc. | -11.96 Million USD | -2962.049% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1320.374% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1114.879% |
| Legend Biotech Corporation | -518.25 Million USD | 29.323% |
| Mural Oncology plc | -207.44 Million USD | -76.568% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -195.118% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -1902.687% |
| Disc Medicine, Inc. | -76.42 Million USD | -379.25% |
| Champions Oncology, Inc. | -7.27 Million USD | -4934.167% |
| REGENXBIO Inc. | -263.49 Million USD | -39.011% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -3351.272% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -671.047% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -864.329% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -265.69% |
| Vaxart, Inc. | -82.46 Million USD | -344.171% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 109844.34% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -875.657% |
| Cellectis S.A. | -101.05 Million USD | -262.448% |
| Longeveron Inc. | -21.41 Million USD | -1610.578% |
| Repare Therapeutics Inc. | -93.79 Million USD | -290.513% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 31.66% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -414.671% |
| Revolution Medicines, Inc. | -436.36 Million USD | 16.06% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -5474.281% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1088.314% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -428.3% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -465.85% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -3633.422% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 110.12% |
| Denali Therapeutics Inc. | -145.22 Million USD | -152.221% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -304493.61% |
| Veru Inc. | -93.15 Million USD | -293.21% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1255.159% |
| Cingulate Inc. | -23.53 Million USD | -1456.349% |
| Passage Bio, Inc. | -102.06 Million USD | -258.886% |
| Context Therapeutics Inc. | -23.96 Million USD | -1428.471% |
| Exicure, Inc. | -16.91 Million USD | -2065.579% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -93.887% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -869.934% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -5528.826% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -98.338% |
| Nuvalent, Inc. | -126.21 Million USD | -190.199% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -3383.244% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -321.605% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1099.208% |
| OmniAb, Inc. | -50.61 Million USD | -623.614% |
| Anew Medical, Inc. | 1.34 Million USD | 27310.4% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -2182.867% |
| Lipocine Inc. | -16.35 Million USD | -2139.996% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -451.685% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -475.243% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -768.104% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -663.621% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1747.037% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 32.356% |
| Ocugen, Inc. | -63.07 Million USD | -480.687% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -282.616% |
| Q32 Bio Inc. | -112.96 Million USD | -224.259% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -2030.561% |
| Alumis Inc. Common Stock | -154.99 Million USD | -136.324% |
| Equillium, Inc. | -13.33 Million USD | -2646.802% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -506.775% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -4485.547% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -1843.035% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -519.962% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -219.825% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -1893.073% |
| Dominari Holdings Inc. | -22.88 Million USD | -1500.76% |
| Edesa Biotech, Inc. | -8.37 Million USD | -4273.87% |
| vTv Therapeutics Inc. | -20.25 Million USD | -1708.82% |
| Bio-Techne Corporation | 168.1 Million USD | 317.891% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -4.033% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 384.267% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -200.648% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -865.46% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -225.177% |
| Nkarta, Inc. | -117.5 Million USD | -211.73% |
| BioCardia, Inc. | -11.57 Million USD | -3065.552% |
| Iterum Therapeutics plc | -38.37 Million USD | -854.591% |